Attached files

file filename
EX-99.1 - PRESS RELEASE DATED NOVEMBER 12, 2015 - GUIDED THERAPEUTICS INCex99one.htm
EX-99.2 - TRANSCRIPT OF CONFERENCE CALL ON NOVEMBER 13, 2015 - GUIDED THERAPEUTICS INCex99two.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

FORM 8-K
 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  November 13, 2015 (November 12, 2015)

 

GUIDED THERAPEUTICS, INC.

 (Exact name of registrant as specified in its charter)

 

         

Delaware

(State or other jurisdiction of incorporation)

 

0-22179

(Commission File Number)

 

58-2029543

(IRS Employer Identification No.)

   

5835 Peachtree Corners East, Suite D

Norcross, Georgia

(Address of principal executive offices)

30092

(Zip Code)

           

 

Registrant’s telephone number, including area code: (770) 242-8723

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  [ ]

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  [ ]

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  [ ]

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 1 
 

 

Section 2.02 Results of Operations and Financial Condition 

On November 12, 2015, the registrant publicly released its financial results for the third quarter and nine months ended September 30, 2015, as more fully described in the press release, a copy of which is furnished as Exhibit 99.1 hereto and which information is incorporated herein by reference.

Item 7.01 Regulation FD Disclosure

 

On November 13, 2015, the registrant conducted a conference call discussing its financial results for the third quarter and nine months ended September 30, 2015, and other matters concerning the operation of the company, as more fully described in the prepared transcript of the call, a copy of which is furnished as Exhibit 99.2 hereto and which information is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits.

Number Exhibit
   
99.1 Press Release dated November 12, 2015
99.2 Transcript of conference call on November 13, 2015

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Date: November 13, 2015  GUIDED THERAPEUTICS, INC.
   
  /s/ Gene S. Cartwright, Ph.D.
   By: Gene S. Cartwright, Ph.D.
           President and Chief Executive Officer

 

 

 2 
 

 

 

EXHIBIT INDEX

Number Exhibit
   
99.1 Press Release dated November 12, 2015
99.2 Transcript of conference call on November 13, 2015

 

 

 

 

 

 3